Falsified medicinal products

This procedure aims to prevent falsified medicines from entering the legal supply chain. By strengthening safety standards and tracking mechanisms, the EU seeks to protect patients from counterfeit drugs that could be ineffective or dangerous.

This affects pharmaceutical manufacturers, wholesalers, and pharmacies. It introduces stricter requirements for product labeling and verification to ensure medicine authenticity for consumers.